48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients Li Gao; Yue Hu; Xiaofeng Shi; Xin Li; Dazhi Zhang; Hong Ren;

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues Yan Gu; Yao Zhang; Zhiyi Zhang; Jian Wang; Qing Zhang; Shaoqiu Zhang; Yilin Liu; Jiacheng Liu; Juan Xia; Xiaomin Yan; Jie Li; Xingxiang Liu; Rui Huang; Chao Wu;

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen;